Discover
AKTS
Aktis Oncology, Inc.
18.15
2 x 13.01
2 x 22.75
bid
ask
+
0.41
2.31%
2 @ 04:01 PM
18.15 +0.00 (0.00%)
| Ytd | -18.97% | |
| 1y | -18.97% |
17.59
day range
18.20
15.19
52 week range
32.23
| Open | 17.74 | Prev Close | 17.74 | Low | 17.59 | High | 18.20 | Mkt Cap | 1.01B |
| Vol | 361.04K | Avg Vol | 366.06K | EPS | -1.70 | P/E | N/A | Forward P/E | -8.45 |
| Beta | N/A | Short Ratio | 10.89 | Inst. Own | 73.01% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 11-12 | 50-d Avg | 22.96 | 200-d Avg | 21.42 | 1yr Est | 35.39 |
| Income Statement | |||
| Total Revenue | 3.38M | ||
| Revenues (USD) | 3.38M | ||
| Gross Profit | 3.38M | ||
| Operating Expenses | 32.28M | ||
| Research and Development Expense | 25.28M | ||
| Selling, General and Administrative Expense | 7.00M | ||
| Operating Income | -28.90M | ||
| Net Income | -24.14M | ||
| Net Income Common Stock | -24.14M | ||
| Net Income Common Stock (USD) | -24.14M | ||
| Consolidated Income | -24.14M | ||
| Earnings per Basic Share | -0.44 | ||
| Earnings per Basic Share (USD) | -0.44 | ||
| Earnings per Diluted Share | -0.44 | ||
| Earning Before Interest & Taxes (EBIT) | -24.14M | ||
| Earning Before Interest & Taxes (USD) | -24.14M | ||
| Weighted Average Shares | 55.30M | ||
| Weighted Average Shares Diluted | 55.30M | ||
| Balance Sheet | |||
| Cash and Equivalents | 83.64M | ||
| Cash and Equivalents (USD) | 83.64M | ||
| Investments | 434.83M | ||
| Investments Current | 434.83M | ||
| Current Assets | 524.54M | ||
| Property, Plant & Equipment Net | 28.20M | ||
| Total Assets | 557.60M | ||
| Debt Current | 1.48M | ||
| Total Debt | 11.24M | ||
| Current Liabilities | 32.13M | ||
| Debt Non-Current | 9.76M | ||
| Total Liabilities | 72.76M | ||
| Accumulated Retained Earnings (Deficit) | -199.03M | ||
| Accumulated Other Comprehensive Income | -745.00K | ||
| Shareholders Equity | 484.84M | ||
| Shareholders Equity (USD) | 484.84M | ||
| Assets Non-Current | 33.06M | ||
| Total Debt (USD) | 11.24M | ||
| Deferred Revenue | 48.21M | ||
| Liabilities Non-Current | 40.63M | ||
| Trade and Non-Trade Payables | 2.53M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 879.00K | ||
| Net Cash Flow from Financing | 156.00K | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | -289.14M | ||
| Capital Expenditure | -1.26M | ||
| Issuance (Purchase) of Equity Shares | 156.00K | ||
| Net Cash Flow from Investing | -268.71M | ||
| Net Cash Flow - Investment Acquisitions and Disposals | -267.45M | ||
| Net Cash Flow from Operations | -20.59M | ||
| Share Based Compensation | 3.22M | ||